| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |